INTRAVENOUS (IV) BUSULFAN (BU) ADMINISTERED TWICE DAILY DURING CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANT (ALLOSCT) IN PEDIATRIC RECIPIENTS HAS SIGNIFICANTLY DIFFERENT HALF-LIFE OF ELIMINATION AND CLEARANCE IN RECIPIENTS > 4 YEARS AND THOSE <= 4 YEARS
Biology of Blood and Marrow Transplantation（2012）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要